Skip to main content
Clinical Trials/NCT03906734
NCT03906734CompletedNot Applicable

Alfieri Stich Versus Secondary Cord Cutting During Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy: A Pilot Randomized Trial

Meshalkin Research Institute of Pathology of Circulation2 sites in 2 countries48 target enrollmentStarted: January 10, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
48
Locations
2
Primary Endpoint
Transmitral pressure gradient

Study Overview

Brief Summary

Objective of the study: to evaluate whether alfieri technique improves clinical and hemodynamic results compared to transaortic mitral valve secondary cord cutting in patients scheduled to septal myectomy for severely symptomatic hypertrophic obstructive cardiomyopathy.

Detailed Description

There is pilot prospective randomised study comparing immediate and early results of additional subvalvular mitral apparatus intervention versus additional alfieri stich in patients scheduled to septal myectomy for symptomatic obstructive cardiomyopathy.

Patients with proven hypertrophic cardiomyopathy and resting left ventricle outflow tract obstruction underwent septal myectomy. If patients were suitable for both surgical techniques, they were randomized to alfieri stich or secondary cord cutting. All surgeons were experienced at least 50 related procedures.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Hypertrophic obstructive cardiomyopathy
  • Left ventricle outflow tract gradient > 50 mm Hg at rest
  • Systolic anterior motion mediated mitral regurgitation

Exclusion Criteria

  • Intrinsic valvular heart disease
  • Coronary artery disease
  • Aortic disease

Outcomes

Primary Outcomes

Transmitral pressure gradient

Time Frame: 30-days

Transmitral pressure gradient after the procedures assessed by echocardiography

Secondary Outcomes

  • Residual left ventricle outflow tract gradient(intraoperative measuerment)
  • Early mortality(30 days)
  • Repeat bypass(30 day)

Investigators

Sponsor
Meshalkin Research Institute of Pathology of Circulation
Sponsor Class
Network
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials